Evidence map›Paper›PMID 36325324›Full record

ArticleFrontiers in immunology2022

Huiya Ma, Hongzhi Yu, Zhengyang Li, Zhi Cao, Youwei Du, Jiangkun Dai, Dongming Zhi, Yujie Xu, Na Li, Junru Wang

Abstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Huiya MaCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, China.
Hongzhi YuCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, China.
Zhengyang LiCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, China.
Zhi CaoCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, China.
Youwei DuCollege of Plant Protection, Northwest A&F University, Yangling, China.
Jiangkun DaiCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, China.
Dongming ZhiCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, China.
Yujie XuCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, China.
Na LiInstrumental Analysis Center, Xi'an Jiaotong University, Xi'an, China.
Junru WangCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsSarcomaAnimalsCarbolinesCell Cycle CheckpointsCell Line, TumorCell ProliferationMiceMolecular Docking SimulationAntineoplastic AgentsCarbolinesnorharmanapoptosisCCNA2CDK2cell cycletumor-infiltrating cellβ-Carboline-3-carboxylic acid dimers

Identifiers

PMID36325324
PMCPMC9618858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.